Segunda citorreducción más quimioterapia hipertérmica intraperitoneal por recaída de seudomixoma peritoneal

Autores/as

  • Mauricio García Instituto Nacional de Cancerología E.S.E
  • Mario Arturo Abadía Instituto Nacional de Cancerología E.S.E
  • Felipe Solórzano Universidad Militar Nueva Granada

DOI:

https://doi.org/10.30944/20117582.25

Palabras clave:

seudomixoma peritoneal, procedimientos quirúrgicos de citorreducción, quimioterapia del cáncer por perfusión regional, neoplasias del apéndice

Resumen

Introducción. El seudomixoma peritoneal es una con- dición rara caracterizada por la presencia de ascitis mucinosa e implantes peritoneales, en la mayoría de los casos, provenientes de tumores mucinosos del apéndice. El tratamiento primario de esta enfermedad es quirúrgi- co, y la citorreducción más quimioterapia hipertérmica intraperitoneal es el estándar de tratamiento actual, con supervivencia global a 5 y 10 años hasta de 96 y 68 %, respectivamente.

No obstante, es una cirugía con alta morbilidad y considerable mortalidad, que apenas se está introdu- ciendo en Colombia y la experiencia es incipiente. El porcentaje de recaída es de 28 a 44 % y existen pocos reportes sobre su manejo; la segunda citorreducción más quimioterapia hipertérmica intraperitoneal parece tener resultados aceptables en cuanto a supervivencia, morbilidad y mortalidad.

Resultados. No hay estudios de segundas intervenciones por recaída peritoneal del seudomixoma en Colombia y, por esta razón, se decidió reportar la experiencia de dos casos del Instituto Nacional de Cancerología, donde, después de una primera citorreducción más quimioterapia hipertérmica intraperitoneal, los pacientes presentaron recaída peritoneal diagnosticada con imágenes durante el seguimiento y fueron sometidos a una nueva cirugía con buen resultado quirúrgico.

Conclusión. La citorreducción secundaria más quimioterapia hipertérmica intraperitoneal es un procedimiento complejo con morbilidad considerable, que debe practicarse en lugares con experiencia y que proporciona al paciente un tratamiento radical y, posiblemente, se convierta en el manejo estándar de la recaída.

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Mauricio García, Instituto Nacional de Cancerología E.S.E

Médico, cirujano oncólogo, Servicio de Seno y Tejidos Blandos, Instituto Nacional de Cancerología E.S.E., Bogotá, D.C., Colombia

Mario Arturo Abadía, Instituto Nacional de Cancerología E.S.E

Médico, cirujano gastrointestinal, Servicio de Cirugía Gastrointestinal, Instituto Nacional de Cancerología E.S.E., Bogotá, D.C., Colombia

Felipe Solórzano, Universidad Militar Nueva Granada

Médico, fellow en Cirugía Oncológica, Instituto Nacional de Cancerología E.S.E.-Universidad Militar Nueva Granada, Bogotá, D.C., Colombia.

Referencias bibliográficas

Limber GK, King RE, Silverberg SG. Pseudomyxoma peritonaei: A report of ten cases. Ann Surg. 1973;178:587-93.

https://doi.org/10.1097/00000658-197311000-00006

Sugarbaker PH, Ronnett BM, Archer A, Averbach AM, Bland R, Chang D, et al. Pseudomyxoma peritonei syndrome. Adv Surg. 1996;30:233-80.

Sugarbaker PH. Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg. 1994;219:109-11.

https://doi.org/10.1097/00000658-199402000-00001

Prayson RA, Hart WR, Petras RE. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol. 1994;18:591-603.

Seidman JD, Elsayed AM, Sobin LH, Tavassoli FA. Association of mucinous tumors of the ovary and appendix. A clinicopatho- logic study of 25 cases. Am J Surg Pathol. 1993;17:22-34.

https://doi.org/10.1097/00000478-199301000-00003

Young RH, Gilks CB, Scully RE. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinico-pathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol. 1991;15:415-29.

https://doi.org/10.1097/00000478-199105000-00001

Mukherjee A, Parvaiz A, Cecil TD, Moran BJ. Pseudomyxoma peritonei usually originates from the appendix: A review of the evidence. Eur J Gynaecol Oncol. 2004;25:411-4.

Rosenberger LH, Stein LH, Witkiewicz AK, Kennedy EP, Yeo CJ. Intraductal papillary mucinous neoplasm (IPMN) with extra- pancreatic mucin: A case series and review of the literature. J Gastrointest Surg. 2012;16:762-70.

https://doi.org/10.1007/s11605-012-1823-8

Agrawal AK, Bobinski P, Grzebieniak Z, Rudnicki J, Marek G, Kobielak P, et al. Pseudomyxoma peritonei originating from urachus-case report and review of the literature. Curr Oncol. 2014;21:e155-65.

https://doi.org/10.3747/co.21.1695

Soto-Delgado M, Pedrero-Márquez G, Varo-Solís C, Rodríguez- Rubio Cortadellas FO, Sánchez-Bernal C, González-Moreno D. Adenocarcinoma mucinoso de uraco y pseudomixoma perito- neal. Actas Urológicas Españolas. 2006;30:222-6.

https://doi.org/10.1016/S0210-4806(06)73427-1

Smeenk RM, van Velthuysen MLF, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: A population based study. Eur J Surg Oncol. 2008;34:196-201.

https://doi.org/10.1016/j.ejso.2007.04.002

Sugarbaker PH. Cytoreductive surgery and intraperitoneal che- motherapy with peritoneal spread of cystadenocarcinoma. Eur J Surg Suppl. 1991;561:75-82.

Sugarbaker PH. Peritonectomy procedures. Surg Oncol Clin N Am. 2003;12:703-2.

https://doi.org/10.1016/S1055-3207(03)00048-6

Gilly FN, Cotte E, Brigand C, Monneuse O, Beaujard AC, Freyer G, et al. Quantitative prognostic indices in peritoneal carcinomatosis. Eur J Surg Oncol. 2006;32:597-601.

https://doi.org/10.1016/j.ejso.2006.03.002

Yan TD, Black D, Savady R, Sugarbaker PH. A systematic re- view on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2007;14:484-92.

https://doi.org/10.1245/s10434-006-9182-x

González-Moreno S, Sugarbaker PH. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg. 2004;91:304-11.

https://doi.org/10.1002/bjs.4393

Bryant J, Clegg AJ, Sidhu MK, Brodin H, Royle P, Davidson P. Systematic review of the Sugarbaker procedure for pseudomyxo- ma peritonei. Br J Surg. 2005;92:153-8.

https://doi.org/10.1002/bjs.4862

Rabelo FEF, de Queiroz FL, do Rego RSN, da Costa BXM, Lamounier PC, de Oliveira TAN, et al. Multimodal treatment of peritoneal malignancies - results of the implantation in a tertiary hospital. Journal of Coloproctology (Rio de Janeiro). 2012;32:106-12.

https://doi.org/10.1590/S2237-93632012000200002

López-Basave HN, Morales-Vásquez F, Ruiz-Molina JM, González-Enciso A, Namendys-Silva SA, Medina-Castro JM, et al. Morbidity and mortality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: National Cancer Institute, Mexico City, Mexico. ISRN Oncol. 2011;2011:526384.

https://doi.org/10.5402/2011/526384

García-Matus R, Hernández-Hernández CA, Leyva-García O, Vásquez-Ciriaco S, Flores-Ayala G, Navarro-Hernández Q, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: Initial experience in Oaxaca, México. Am Surg. 2012;78:942-6.

Otero J, Árias F, Londoño E, Mora M, Becerra H, Cortés N, et al. Peritonectomía radical y quimioterapia intraperitoneal: cinco años de experiencia en la Fundación Santa Fe de Bogotá (ONCOL Group - Estudio ATIA). Rev Colomb Hematol Oncol. 2013;2:22-33.

Árias F, Otero JM, Guerrero C, Cardona AF, Vargas CA, Car- ranza H, et al. Pseudomyxoma peritonei: First cases treated by radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Rev Colomb Cir. 2009;24:184-94.

Elias D, Laurent S, Antoun S, Duvillard P, Ducreux M, Pocard M, et al. Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy. Gastroenterol Clin Biol. 2003;27:407-12.

Smeenk RM, Bruin SC, van Velthuysen M-LF, Verwaal VJ. Pseudomyxoma peritonei. Curr Probl Surg. 2008;45:527-75.

https://doi.org/10.1067/j.cpsurg.2008.04.003

Cuatrecasas M, Matias-Guiu X, Prat J. Synchronous mucinous tumors of the appendix and the ovary associated with pseu- domyxoma peritonei. A clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations. Am J Surg Pathol. 1996;20:739-46.

https://doi.org/10.1097/00000478-199606000-00012

Chuaqui RF, Zhuang Z, Emmert-Buck MR, Bryant BR, Nogales F, Tavassoli FA, et al. Genetic analysis of synchronous mucinous tumors of the ovary and appendix. Hum Pathol. 1996;27:165-71.

https://doi.org/10.1016/S0046-8177(96)90370-6

Young RH. From Krukenberg to today: The ever present pro- blems posed by metastatic tumors in the ovary: Part I. Historical perspective, general principles, mucinous tumors including the Krukenberg tumor. Adv Anat Pathol. 2006;13:205-27.

https://doi.org/10.1097/01.pap.0000213038.85704.e4

Young RH. Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms. Semin Diagn Pathol. 2004;21:134-50.

https://doi.org/10.1053/j.semdp.2004.12.002

Smith JW, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A. Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer. 1992;70:396-401.

https://doi.org/10.1002/1097-0142(19920715)70:2<396::AID-CNCR2820700205>3.0.CO;2-A

Esquivel J, Sugarbaker PH. Clinical presentation of the pseu- domyxoma peritonei syndrome. Br J Surg. 2000;87:1414-8.

https://doi.org/10.1046/j.1365-2168.2000.01553.x

Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: Retros- pective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies. Dis Colon Rectum. 1998;41:75-80.

https://doi.org/10.1007/BF02236899

Turaga KK, Pappas SG, Gamblin TC. Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol. 2012;19:1379-85.

https://doi.org/10.1245/s10434-012-2238-1

Marudanayagam R, Williams GT, Rees BI. Review of the pathological results of 2660 appendicectomy specimens. J Gastroenterol. 2006;41:745-9.

https://doi.org/10.1007/s00535-006-1855-5

Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseu- domyxoma peritonei." Am J Surg Pathol. 1995;19:1390-408.

https://doi.org/10.1097/00000478-199512000-00006

Misdraji J, Yantiss RK, Graeme-Cook FM, Balis UJ, Young RH. Appendiceal mucinous neoplasms: A clinico-pathologic analysis of 107 cases. Am J Surg Pathol. 2003;27:1089-103.

https://doi.org/10.1097/00000478-200308000-00006

Pai RK, Beck AH, Norton JA, Longacre TA. Appendiceal mu- cinous neoplasms: Clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Am J Surg Pathol. 2009;33:1425-39.

https://doi.org/10.1097/PAS.0b013e3181af6067

Bradley RF, Stewart JH, Russell GB, Levine EA, Geisin- ger KR. Pseudomyxoma peritonei of appendiceal origin: A clinico-pathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol. 2006;30:551-9.

https://doi.org/10.1097/01.pas.0000202039.74837.7d

Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classifi- cation of tumours of the digestive system. Fourth edition. Lyons: IARC; 2010. p. 417.

Carr NJ, McCarthy WF, Sobin LH. Epithelial noncarcinoid tu- mors and tumor-like lesions of the appendix. A clinicopathologic study of 184 patients with a multivariate analysis of prognostic factors. Cancer. 1995;75:757-68.

https://doi.org/10.1002/1097-0142(19950201)75:3<757::AID-CNCR2820750303>3.0.CO;2-F

Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugar- baker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001;92:85-91.

https://doi.org/10.1002/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R

Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, González-Moreno S, et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: The results of the Peritoneal Surface On- cology Group International (PSOGI) Modified Delphi Process. Am J Surg Pathol. 2016;40:14-26.

https://doi.org/10.1097/PAS.0000000000000535

Jiménez W, Sardi A, Nieroda C, Sittig M, Milovanov V, Núñez M, et al. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21:4218-25.

https://doi.org/10.1245/s10434-014-3869-1

Sugarbaker PH, Alderman R, Edwards G, Marquardt CE, Gus- hchin V, Esquivel J, et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperi- toneal chemotherapy to treat peritoneal dissemination of appen- diceal mucinous malignancy. Ann Surg Oncol. 2006;13:635-44.

https://doi.org/10.1245/ASO.2006.03.079

Moran B, Baratti D, Yan TD, Kusamura S, Deraco M. Consensus statement on the loco-regional treatment of appendiceal muci- nous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol. 2008;98:277-82.

https://doi.org/10.1002/jso.21054

Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003;12:585-603.

https://doi.org/10.1016/S1055-3207(03)00026-7

Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7:69-76.

https://doi.org/10.1016/S1470-2045(05)70539-8

Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, et al. Peritonectomy and intraperitoneal hyperthermic perfu- sion (IPHP): A strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol. 2004;11:393-8.

https://doi.org/10.1245/ASO.2004.07.002

Youssef H, Newman C, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin. Dis Colon Rectum. 2011;54:293-9.

https://doi.org/10.1007/DCR.0b013e318202f026

Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intra- peritoneal chemotherapy. J Clin Oncol. 2012;30:2449-56.

https://doi.org/10.1200/JCO.2011.39.7166

Votanopoulos KI, Shen P, Stewart JH, Levine EA. Current sta- tus and future directions in appendiceal cancer with peritoneal dissemination. Surg Oncol Clin N Am. 2012;21:599-609.

https://doi.org/10.1016/j.soc.2012.07.012

Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR, Wilson TO, et al. Pseudomyxoma peritonei. Long-term pa- tient survival with an aggressive regional approach. Ann Surg. 1994;219:112-9.

https://doi.org/10.1097/00000658-199402000-00002

Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG. Long-term survival following treatment of pseudomyxoma peri- tonei: An analysis of surgical therapy. Ann Surg. 2005;241:300-8.

https://doi.org/10.1097/01.sla.0000152015.76731.1f

Esquivel J, Sugarbaker PH. Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: Analysis of prognostic factors in 98 patients. Ann Surg. 2001;234:198- 205.

https://doi.org/10.1097/00000658-200108000-00009

Sardi A, Jiménez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: Analysis of survival outcomes. Eur J Surg Oncol. 2013;39:1207-13.

https://doi.org/10.1016/j.ejso.2013.08.017

Votanopoulos KI, Ihemelandu C, Shen P, Stewart JH, Russell GB, Levine EA. Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. J Am Coll Surg. 2012;215: 412-7.

https://doi.org/10.1016/j.jamcollsurg.2012.04.023

Yan TD, Bijelic L, Sugarbaker PH. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol. 2007;14:2289-99.

https://doi.org/10.1245/s10434-007-9462-0

Elias D, Honoré C, Ciuchendéa R, Billard V, Raynard B, Lo Dico R, et al. Peritoneal pseudomyxoma: Results of a systema- tic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg. 2008;95:1164-71.

https://doi.org/10.1002/bjs.6235

Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FAN. Survival analysis of pseudomyxoma peritonei patients treated by cytore- ductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007;245:104-9.

https://doi.org/10.1097/01.sla.0000231705.40081.1a

Chua TC, Liauw W, Morris DL. Early recurrence of pseu- domyxoma peritonei following treatment failure of cytoreduc- tive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome. Int J Colorectal Dis. 2012;27:381-9.

https://doi.org/10.1007/s00384-011-1303-8

Brouquet A, Goéré D, Lefèvre JH, Bonnet S, Dumont F, Raynard B, et al. The second procedure combining complete cytoreduc- tive surgery and intraperitoneal chemotherapy for isolated peri- toneal recurrence: Postoperative course and long-term outcome. Ann Surg Oncol. 2009;16:2744-51.

https://doi.org/10.1245/s10434-009-0611-5

Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, et al. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: Postoperative and long-term results. J Surg Oncol. 2012;106:197-203.

https://doi.org/10.1002/jso.23062

Descargas

Publicado

2017-09-20

Cómo citar

(1)
García, M.; Abadía, M. A.; Solórzano, F. Segunda citorreducción más Quimioterapia hipertérmica Intraperitoneal Por recaída De Seudomixoma Peritoneal. Rev Colomb Cir 2017, 32, 193-204.

Número

Sección

Artículo Original

Métricas

QR Code

Algunos artículos similares: